RNA-based Therapeutics and Vaccines Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Table of Content

1. Executive Summary
   1. Global RNA-based Therapeutics and Vaccines Market Snapshot, 2026 and 2033
   2. Market Opportunity Assessment, 2026 – 2033, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors – Relevance and Impact
3. Value Added Insights
   1. Regulatory Landscape
   2. Product Adoption Analysis
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global RNA-based Therapeutics and Vaccines Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2020-2025
      2. Market Size (US$ Mn) Analysis and Forecast, 2026–2033
   3. Global RNA-based Therapeutics and Vaccines Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2020 – 2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
         1. RNA-based Therapeutics
            1. siRNA
            2. miRNA
         2. RNA-based Vaccines
            1. mRNA
      4. Market Attractiveness Analysis: Product
   4. Global RNA-based Therapeutics and Vaccines Market Outlook: Indication Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication Type, 2020 – 2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
         1. Oncology
         2. Immunology
         3. Ophthalmology
         4. Cardiovascular Diseases
         5. Infectious Diseases
         6. Genetic Diseases
         7. Others
      4. Market Attractiveness Analysis: Indication Type
5. Global RNA-based Therapeutics and Vaccines Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2020 – 2025
   3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America RNA-based Therapeutics and Vaccines Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
   4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
         1. siRNA
         2. miRNA
      2. RNA-based Vaccines
         1. mRNA
   5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
   6. Market Attractiveness Analysis
7. Europe RNA-based Therapeutics and Vaccines Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
         1. siRNA
         2. miRNA
      2. RNA-based Vaccines
         1. mRNA
   5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
   6. Market Attractiveness Analysis
8. East Asia RNA-based Therapeutics and Vaccines Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
         1. siRNA
         2. miRNA
      2. RNA-based Vaccines
         1. mRNA
   5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
   6. Market Attractiveness Analysis
9. South Asia & Oceania RNA-based Therapeutics and Vaccines Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
         1. siRNA
         2. miRNA
      2. RNA-based Vaccines
         1. mRNA
   5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
   6. Market Attractiveness Analysis
10. Latin America RNA-based Therapeutics and Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
       1. By Country
       2. By Product
       3. By Indication Type
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
       1. RNA-based Therapeutics
          1. siRNA
          2. miRNA
       2. RNA-based Vaccines
          1. mRNA
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
       1. Oncology
       2. Immunology
       3. Ophthalmology
       4. Cardiovascular Diseases
       5. Infectious Diseases
       6. Genetic Diseases
       7. Others
    6. Market Attractiveness Analysis
11. Middle East & Africa RNA-based Therapeutics and Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
       1. By Country
       2. By Product
       3. By Indication Type
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
       1. RNA-based Therapeutics
          1. siRNA
          2. miRNA
       2. RNA-based Vaccines
          1. mRNA
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
       1. Oncology
       2. Immunology
       3. Ophthalmology
       4. Cardiovascular Diseases
       5. Infectious Diseases
       6. Genetic Diseases
       7. Others
    6. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       1. Alnylam Pharmaceuticals, Inc.
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Arbutus Biopharma Corp.
       3. Arrowhead Pharmaceuticals, Inc.
       4. BioNTech AG
       5. CureVac AG
       6. Dicerna Pharmaceuticals, Inc.
       7. Regulus Therapeutics, Inc.
       8. Marina Biotech, Inc.
       9. miRagen Therapeutics
       10. Moderna Therapeutics, Inc.
       11. Quark Pharmaceuticals, Inc.
       12. Santaris Pharma A/S (A Roche Company)
       13. Sylentis S.A.
       14. Others   
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations